Bemarituzumab in Patients with Fgfr2B-Selected Gastric or Gastro-Oesophageal Junction Adenocarcinoma (Fight) : a Randomised, Double-Blind, Placebo-Controlled, Phase 2 Study

AuthID
P-00X-D3K
21
Author(s)
Wainberg, ZA
·
Enzinger, PC
·
Qin, SK
·
Yamaguchi, K
·
Kim, IH
·
Saeed, A
·
Oh, SC
·
Li, J
·
Turk, HM
·
[+1]·
Hitre, E
·
Udrea, AA
·
Sanchez, RG
·
Mitra, S
·
Yang, YS
·
Lee, KW
Document Type
Article
Year published
2022
Published
in LANCET ONCOLOGY, ISSN: 1470-2045
Volume: 23, Issue: 11, Pages: 1430-1440 (11)
Indexing
Publication Identifiers
Pubmed: 36244398
Scopus: 2-s2.0-85140889719
Wos: WOS:000886922400038
Source Identifiers
ISSN: 1470-2045
Export Publication Metadata
Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.



CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Name Order Name   Name Order Name   Name Order Name
1 Wainberg, ZA;   2 Enzinger, PC;   3 Kang, YK;
4 Qin, SK;   5 Yamaguchi, K;   6 Kim, IH;
7 Saeed, A;   8 Oh, SC;   9 Li, J;
10 Turk, HM;   11 Teixeira, A;   12 Borg, C;
13 Hitre, E;   14 Udrea, AA;   15 Cardellino, GG;
16 Sanchez, RG;   17 Collins, H;   18 Mitra, S;
19 Yang, YS;   20 Catenacci, DVT;   21 Lee, KW;